NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Herpes zoster
Date of first enrollment	08/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : AK-120 INN of investigational material : Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Efficacy, safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 80age old
Gender	Both
Include criteria	Inclusion criteria 1) patients diagnosed with herpes zoster; 2) patients in whom the study drug can be administered within 72 hours of onset of the zoster rash; 3) patients in whom edematous erythema is observed before the development of vesicles are noted; 4) patients aged 20 to 80 years; 5) patient can be either male or female. Exclusion criteria 1) patients with severe herpes zoster in whom sufficient therapeutic benefit cannot be anticipated from oral medication; 2) patients whose clinical conditions are diagnosed as evidencing either immunodeficiency or depressed immune functions; 3) patients with a past history of herpes zoster; 4) patients whose lesions have started to crust.
Exclude criteria